temozolomide has been researched along with Fever in 4 studies
Fever: An abnormal elevation of body temperature, usually as a result of a pathologic process.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Temozolomide (TMZ) is a methylating agent that spontaneously decomposes into the active metabolite of dacarbazine, the most effective agent for the systemic treatment of melanoma." | 5.34 | Combined effect of temozolomide and hyperthermia on human melanoma cell growth and O6-methylguanine-DNA methyltransferase activity. ( Bonmassar, E; Caporali, S; Caporaso, P; D'Atri, S; Falcinelli, S; Pagani, E; Pepponi, R; Turriziani, M, 2007) |
| "Two patients, a 58-year-old man and a 55-year-old woman, both under treatment for glioblastoma multiforme, were admitted with fever and neutropenia a few weeks after starting to take the oncolytic agent temozolomide." | 3.74 | [Temozolomide, an oral chemotherapeutic agent with potential severe toxicity]. ( Gijtenbeek, JM; Kappelle, AC; Soetekouw, PM; van der Maazen, RW; van Herpen, CM, 2007) |
| "Temozolomide is an alkylating agent used frequently in the management of gliomas." | 2.44 | Prolonged and severe myelosuppression in two patients after low-dose temozolomide treatment- case study and review of literature. ( Brown, MP; Selva-Nayagam, S; Singhal, N, 2007) |
| "Temozolomide (TMZ) is a methylating agent that spontaneously decomposes into the active metabolite of dacarbazine, the most effective agent for the systemic treatment of melanoma." | 1.34 | Combined effect of temozolomide and hyperthermia on human melanoma cell growth and O6-methylguanine-DNA methyltransferase activity. ( Bonmassar, E; Caporali, S; Caporaso, P; D'Atri, S; Falcinelli, S; Pagani, E; Pepponi, R; Turriziani, M, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Seiter, K | 1 |
| Liu, D | 1 |
| Siddiqui, AD | 1 |
| Lerner, R | 1 |
| Nelson, J | 1 |
| Ahmed, T | 1 |
| Pagani, E | 1 |
| Falcinelli, S | 1 |
| Pepponi, R | 1 |
| Turriziani, M | 1 |
| Caporaso, P | 1 |
| Caporali, S | 1 |
| Bonmassar, E | 1 |
| D'Atri, S | 1 |
| Soetekouw, PM | 1 |
| Gijtenbeek, JM | 1 |
| van der Maazen, RW | 1 |
| Kappelle, AC | 1 |
| van Herpen, CM | 1 |
| Singhal, N | 1 |
| Selva-Nayagam, S | 1 |
| Brown, MP | 1 |
1 review available for temozolomide and Fever
| Article | Year |
|---|---|
Prolonged and severe myelosuppression in two patients after low-dose temozolomide treatment- case study and review of literature.
Topics: Antineoplastic Agents, Alkylating; Bone Marrow; Bone Marrow Diseases; Brain Neoplasms; Cranial Irrad | 2007 |
1 trial available for temozolomide and Fever
| Article | Year |
|---|---|
Evaluation of temozolomide in patients with myelodysplastic syndrome.
Topics: Aged; Anemia; Antineoplastic Agents, Alkylating; Cardiomyopathies; Dacarbazine; Drug Evaluation; Fem | 2004 |
2 other studies available for temozolomide and Fever
| Article | Year |
|---|---|
Combined effect of temozolomide and hyperthermia on human melanoma cell growth and O6-methylguanine-DNA methyltransferase activity.
Topics: Antineoplastic Agents, Alkylating; Base Pair Mismatch; Cancer Vaccines; Cell Line, Tumor; Cell Proli | 2007 |
[Temozolomide, an oral chemotherapeutic agent with potential severe toxicity].
Topics: Antineoplastic Agents, Alkylating; Dacarbazine; Fatal Outcome; Female; Fever; Glioblastoma; Humans; | 2007 |